Table 1.
The association of SOCS2-AS1 expression in 72 endometrial cancer patients with clinicopathologic characteristics.
| SOCS2-AS1 | |||||
|---|---|---|---|---|---|
| Parameters | Total | Low (no.) | High (no.) | χ2 | P value |
| Age (years) | 1.131 | 0.288 | |||
| <50 | 61 | 40 | 21 | ||
| ≥50 | 11 | 9 | 2 | ||
| Histology grade | 0.762 | 0.383 | |||
| G1+G2 | 62 | 41 | 21 | ||
| G3 | 10 | 8 | 2 | ||
| Clinical stage | 4.917 | 0.027 | |||
| I+II | 58 | 36 | 22 | ||
| III+IV | 14 | 13 | 1 | ||
| Ki67 staining | 5.133 | 0.023 | |||
| <50 | 46 | 27 | 19 | ||
| ≥50 | 26 | 22 | 4 | ||
| Pathologic type | 0.353 | 0.553 | |||
| Endometrioid | 67 | 45 | 22 | ||
| Non-endometrioid | 5 | 4 | 1 | ||
| Depth of myometrial invasion | 1.647 | 0.199 | |||
| <1/2 | 56 | 36 | 20 | ||
| ≥1/2 | 16 | 13 | 3 | ||
| Lymph node metastasis | 0.006 | 0.937 | |||
| No | 43 | 33 | 10 | ||
| Yes | 4 | 3 | 1 | ||
Items with statistical differences are shown in bold.